CD24 and breast cancer: In this regard, one study confirmed a putative stem cell phenotype in disseminated tumor cells (DTCs) [11], and another study showed that the majority of early DTCs detected in the bone marrow of breast cancer patients with a CD44+/CD24- phenotype correlated with a higher prevalence of bone metastases [12].